This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

IMPak Health Releases The Kraken

Kraken is the solution to medication monitoring

NEPTUNE, N.J., Jan. 31, 2013 /PRNewswire-USNewswire/ -- Nearly 50% of the prescriptions written every year in the United States aren't taken as directed – or at all.

As an increasing number of patients refuse to comply with their own physician's medication guidelines, so spikes our country's number of acute care and nursing home admissions, physician visits – and a cost to America that's currently estimated by the New England HealthCare Institute to be $290 billion – and rising.

"When patients are being discharged home from the hospital, they are more vulnerable to medication adherence challenges," said James Clarke, MD, vice president of clinical effectiveness at Ocean Medical Center. "If patients do not take their prescriptions as prescribed by their physician, they are at risk for preventable emergency room visits and hospital admissions." 

"All hospitals are focused on trying to reduce preventable readmissions, and lack of compliance with medication is area of focus to improve overall patient care," he added.  In response to this growing problem, iMPak Health has released their latest product: Kraken.

Kraken is the iMPak Health solution to medication monitoring in the digital age, a unique, user friendly alternative allowing patients and physicians to organize, track and outline prescription schedules freely and accurately.

Here's how Kraken works:
  1. Users update medication management system according to prescription schedule
  2. Data is uploaded to a Bluetooth 4.0 enabled device using the Kraken app
  3. Data is ready to share with individual physicians or family members in the form of a compliance report

With Kraken, iMPak Health aims to simplify the core elements of medication management, including sorting and reminding, compliance and symptom tracking.  With the increasing push toward "performance based" payment initiatives, it is becoming even more important to track not only compliance, but patients' overall reaction to medication.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.55 -1.30%
FB $116.98 0.21%
GOOG $694.01 0.43%
TSLA $246.69 -0.41%
YHOO $36.48 -0.30%


Chart of I:DJI
DOW 17,769.84 -60.92 -0.34%
S&P 500 2,065.48 -10.33 -0.50%
NASDAQ 4,776.4730 -28.8180 -0.60%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs